Retinal Imaging Using NOTAL-OCT V2.5

NCT03600519 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 87

Last updated 2020-11-13

No results posted yet for this study

Summary

Primary objectives:

To compare between retinal measurements, done by the NOTAL-OCT V2.5 device and a commercial OCT.

Secondary objectives:

1. To evaluate the level of agreement between the NOTAL-OCT V2.5 and a commercial OCT in the presence of fluid as identified in the OCT images, in the central 10 degrees of the macula.
2. To evaluate the repeatability of the NOTAL-OCT V2.5

Conditions

Interventions

DEVICE

NOTAL OCT V2.5

AMD Patients

Sponsors & Collaborators

  • Notal Vision Ltd.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-22
Primary Completion
2019-02-18
Completion
2020-01-01

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03600519 on ClinicalTrials.gov